Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-23
2007-01-23
Hui, San-Ming (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
10363430
ABSTRACT:
The present invention relates to methods of treating conditions and/or symptoms related to common cold of the upper and/or lower respiratory tract and/or eyes. In particular the invention relates to the methods of treating conditions and/or symptoms related to common cold comprising administration of a flavonoid or administration of a flavonoid in combination with a metal. The invention furthermore describes compositions comprising a metal and a flavonoid useful for the treatment of conditions and/or symptoms relates to common cold.
REFERENCES:
patent: 3516984 (1970-06-01), Courbat
patent: 4888326 (1989-12-01), Horrobin
patent: 4956385 (1990-09-01), Eby, III
patent: 02076422 (2002-10-01), None
Rink and Kirchner, Journal of Nutrition. 2000;130:1407S-1411S, the content of the paper has been presented in Nov. 1998.
Bardsley-Elliot, Drugs, 1999;58(5):851-860.
“The Merck Manual of Diagnosis and Therapy”, Merck Research Laboratories, Seventeenth Edition, Whitehouse Station, N.J., pp. 556-569, chapter 68, section 6, 1999.
Michael Hermann Hinz, Neuartige Wirkoffkomination von bioligisch hochwirksamen Flouriden u. Flavonoiden zur Therapie und Prphylaxe von Zahnerkrankungen. DE 19949575 Apr. 19, 2001, ISR Sep. 13, 2002.
Andreas Vincze, Hans-Jürgen Reimann, Pharmazeutische Zubereitung, die als aktive Substanz eine Mischung von (+) Catechin und ascorbolysinat enthält, DE 3603227 Aug. 8, 1987, ISR Sep. 13, 2002.
Ismail Roshdy, Vitamin E-haltiges Mittel zur verbesserung der Eigenschaften des Blutes, EP 0204987 Dec. 17, 1986, ISR Sep. 13, 2002.
Yin Hwee Tan, Use of fatty acids for the treatment of diseases associated with cytokines. EP 0396251 Nov. 7, 1990.
Tadakatsu Shimamura, Yukihiko Hara, Preventive and curative midicament against infection with influenza virus, containing tea or tea polyphenols. EP 0417385 Mar. 20, 1991, ISR Sep. 13, 2002.
Joseph A. Deihl, Vitamin-mineral treatment methods and compositions, EP 0754450 Jan. 22, 1997, ISR Sep. 13, 2002.
Thomas Coleman, Nasal spray for treating viral common colds. EP 0861662 Sep. 2, 1998, ISR Sep. 13, 2002.
Kayano Masako, Yazawa Toshiya, Shigeta Shiro, Baba Masanori, Anti-RS virus agent, JP 04368331 Dec. 21, 1992.
M. Kumai, Cold-preventing troche used orally to inhibit virus—consist of layered structure contg. Catechin, Iysozyme, vitamin=C and puerariae radix. JP 08239319.
Shiba Kozaburo, Fanctional japanese apricot chocolate, JP 09056333 Mar. 4, 1997.
Nakayama Mikio, Chewing gum and its production, JP 10257856 Sep. 29, 1998, ISR Sep. 13, 2002.
Kitasato Kenkyusho, Anti-influenza virus agent—contains flavonoid(s) and cellulose ether(s). JP 09227373.
Tsunoda Kenji, Nasal composition, JP 10110785 Nov. 2, 1999, ISR Sep. 13, 2002.
Fukuda Shigeatsu, Composition, JP 11100325, Apr. 4, 1999, ISR Sep. 13, 2002.
Kitajima Hideaki, Okudaira Ichiro, Tsunoda Kenji, Nasal composition, JP 11302184 Nov. 2, 1999.
Taisho Pharm Co. Ltd, Composition for mocous membranes for alleviating symptoms caused by excessive promotion of secretory glands e.g. pollen allergy, comprises a polyphenol. JP 2000327573.
Pierre J. Courbat, Abstract of the disclosure, US 3420815 Jan. 7, 1969.
John R. Casley-Smith, Treatment of high protein oedemas, US 5096887 Mar. 17, 1992, ISR Sep. 13, 2002.
Quing Non Yng-Wong, Antiviral and antimicrobial herbal complex, US 5834000 Nov. 10, 1998.
Kazuo Nashimoto, Yoshikazu Tashiro, Gargling cup, antiviral mask, antiviral filter, antifungal, antibacterial, and antiviral filter air-cleaner humidifier, US 5888527 Mar. 30, 1999, ISR Sep. 13, 2002.
Marion Man-Ying Chan, Method of inhibiting nitric oxide synthase, US 5922756 Jul. 13, 1999, ISR Sep. 13, 2002.
Masayoshi Yamaguchi, Composition for stimulating osteogenesis and preventingreduction of bone salt. US 5935996 Aug. 10, 1999, ISR Sep. 13, 2002.
Shibuya, Takashi, Ario, Takeshi, Fukuda, Shigeharu, Composition, US 6224872 May 1, 2001, ISR Sep. 13, 2002.
R. T. Jordan, L. M. Allen, Lipoxygenase inhibitors, WO 88/03800 Jun. 2, 1988, ISR Sep. 13, 2002.
R. T. Jordan, L. M. Allen, Pharmacologically active compounds and mixtures thereof, organic compositions and metal salts. WO 88/03805 Jun. 2, 1988, ISR Sep. 13, 2002.
K. A. Jacobson, J. Jiang, Y. Karton, A. M. Van Rhee, Dihydropyridine-, pyridine-, benzopyran-, one- and trizoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists. WO 97/27177 Jul. 31, 1997, ISR Sep. 13, 2002.
D. P. Jones, S. Furukawa, Compounds and their combinations for the treatment of influenza infection. WO 98/30228 Jul. 16, 1998, ISR Sep. 13, 2002.
F. Stanislaus, Stabilized medicaments containing cysteinyl derivatives, WO 98/47534, Oct. 29, 1998, ISR Sep. 13, 2002.
Weider Nutrition International, INC. Compositions and treatments to reduce side effects of administration of androgenic testoterone precursors. WO 99/07381 Feb. 18, 1999, ISR Sep. 13, 2002.
P. Han, Q. Guo, Afagopyrum cymosum(trev.) meisn composition, method to prepare and analyze the same and uses thereof. WO99/16319 Apr. 8, 1999, ISR Sep. 13, 2002.
M. Heng, Method for using soluble curcumin to inhibit phosphorylase kinase in inflammatory diseases. WO 00/70949 Nov. 30, 2000.
P. T. Prendergast, Use of flavones, coumarins and related compounds to treat infections. WO 01/03681 Jan. 18, 2001.
L. Kurppa, Flavonoid drug and dosage form, its production and use. WO 01/49285 Jul. 12, 2001.
M. H. Beers, M. d. berkow, The Merch manual of diagnosis and therapy, p. 1277-1293, 1999 Merck Research, ISR Sep. 13, 2002.
J. V. Formica, W. Regelson, Review of the biology of quercetin and related bioflavonoids. Fd Chem. Toxic. vol. 33, No. 12, pp. 1061-1080, 1995.
J. E. F. Reynolds, Martindale- the extra phamacopoeia, thirty-first edition, pp. 1679-1680, 1996, ISR Sep. 13, 2002.
K. Parfitt, Matindale—The complete drug reference . . . pp. 1373-1374, ISR Sep. 13, 2002.
Tej N. Kaul, Elliot Middleton Jr., Pearay L. Ogra. Antiviral effect of flavonoids on human viruses, Journal of Medical Virology 15:71-79, 1985.
S. B. Mossad, M. L. Macknin, S. V. Medendorph, P. Mason, Zinc gluconate lozenges for treating the common cold, Annals of internal medicine, vol. 125, p. 81-88, 1996.
I.M. Selivanova, N.A. Tyukavkina, Yu.A. Kolesnik, V.K. Kolkhir, V.Lyubimov, Investigation of absorption of diquertin in vitro gastrointestinal model, Farmatsiya, 47:27-28, 1998.
M. Tordea, M. L. Ferrándiz, M. J. Alcaraz, Influence of anti-inflammatory flavonoids on degranulation and arachidonic acid release in rat neutrophils, Z. Naturforsch, vol. 49, p. 235-240, 1993.
Baumann, et al., “Flavonoids and Related Compounds as Inhibitors of Arachidonic Acid Peroxidation”,Prostaglandins, Jul. 1980.
Cooper Iver P.
Hui San-Ming
Immupharm APS
LandOfFree
Method of treating symptoms of common cold, allergic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating symptoms of common cold, allergic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating symptoms of common cold, allergic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3738566